http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9234f89b41880c1b4c51255ed9744d49
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Regan |
| name | Meredith M. Regan Meredith M Regan |
| given-name | Meredith M Meredith M. |
| organization-name | Department of Biostatistics and Computational Biology Dana‐Farber Cancer Institute Boston Massachusetts 2Biostatistics and Computational Biology, Dana-Farber Cancer Institute; and From the Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute, Boston, MA; Loyola University Chicago, Maywood; University of Illinois at Chicago, Chicago, IL; Wayne State University, Detroit, MI; University of Texas, San Antonio, TX; Pittsburgh Cancer Institute, Pittsburgh, PA; Indiana University, Indianapolis, IN; Dartmouth Hitchcock Medical Center, Hanover, NH; Earle Chiles Cancer Center, Portland, OR; City of Hope Comprehensive Cancer Center, Duarte, CA; and Our Lady of Mercy, Bronx, NY Division of Gastroenterology; Division of Medicine, Beth Israel Deaconess Medical Center, Boston; Department of Pediatrics, University of Massachusetts Memorial Health Care, University of Massachusetts Medical School, Worcester, Massachusetts From the Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Harvard Medical School, Boston; University of Massachusetts Memorial Medical Center, Worcester, MA; and Dartmouth Hitchcock Medical Center, Lebanon, NH From the Division of General Internal Medicine, Brigham and Women's Hospital; Departments of Health Care Policy and Medicine, Harvard Medical School; and the Departments of Medical Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA Thomas Ruhstaller, MD, Kantonsspital St Gallen, St Gallen, Universitatsspital Basel, Basel, and International Breast Cancer Study Group, Bern, Switzerland; and Meredith M. Regan, ScD, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA and International Breast Cancer Study Group, Bern, Switzerland 2Harvard Medical School, Boston, Massachusetts,; 12Dana-Farber Harvard Comprehensive Cancer Center, Boston, Massachusetts IBCSG Statistical Center Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. [email protected] IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA Biometrics Center1 and Mitch Dowsett and Andrew Dodson, Royal Marsden Hospital; Mitch Dowsett, Institute of Cancer Research; Ivana Sestak and Jack Cuzick, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom; Meredith M. Regan, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA; Giuseppe Viale, University of Milan; Guiseppe Viale and Marco Colleoni, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital St Gallen, St Gallen, and International... Harvard Medical School Boston Massachusetts; Department of Biostatistics and Computational Biology Dana‐Farber Cancer Institute Boston Massachusetts Meritxell Bellet and Analía Azaro, Vall d’Hebron Institute of Oncology; Meritxell Bellet, Roser Ferrer, Roberto Catalán, and Analía Azaro, Vall d’Hebron University Hospital; Meritxell Bellet, Universitat Autònoma de Barcelona; Meritxell Bellet, Eva Ciruelos, Ana Lluch, Miguel Angel Climent, Gustavo Catalán, Antoni Avella, Uriel Bohn, Antonio González-Martin, Josefa Morales, and Josep Vázquez, SOLTI Group, Barcelona; Eva Ciruelos, University Hospital 12 de Octubre; Antonio González-Martin, MD Anderson... 3Biostatistics and Computational Biology, Dana-Farber Cancer Institute;; 4Harvard Medical School, Boston, Massachusetts; and Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA;... Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana Farber Cancer Institute, Boston, MA Division of Urologic Surgery, Beth Israel Deaconess Medical Center and Department of Biostatistical Science, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA International Breast Cancer Study Group Statistical Center, Department of Data Sciences, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. Electronic address: [email protected]. Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA Marianne Ewertz, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense; Bent Ejlertsen, Danish Breast Cancer Cooperative Group Statistical Center and Rigshospitalet, Copenhagen University Hospital; Henning Mouridsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Kathryn P. Gray and Meredith M. Regan, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School; Karen... Poornima Saha and Gini F. Fleming, The University of Chicago Medical Center, Chicago, IL; Meredith M. Regan, Weixiu Luo, Harold J. Burstein, and Richard D. Gelber, Dana-Farber Cancer Institute; Meredith M. Regan, Harold J. Burstein, and Richard D. Gelber, Harvard Medical School; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA; Olivia Pagani, Institute of Oncology of Southern Switzerland,... Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA All authors: Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; and Richard D. Gelber, Harvard School of Public Health, Boston, MA. Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. [email protected] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts Andrew D. Seidman, Memorial Sloan Kettering Cancer Center; Dawn L. Hershman, Columbia University, New York, NY; Louise Bordeleau, Hamilton Health Sciences and Canadian Cancer Trials Group, Hamilton, Ontario, Canada; Louis Fehrenbacher, Kaiser Permanente, Vallejo, CA; William E. Barlow, Cancer Research and Biostatistics, Seattle, WA; Jane Perlmutter, Gemini Group, Ann Arbor, MI; Lawrence Rubinstein, Jennifer Fallas Hayes, and Larissa A. Korde, National Cancer Institute; Lynn Pearson Butler, The Emmes... Authors' Affiliations: Departments of 1Medical Oncology and 2Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts; and 3Department of Medical Oncology, Mount Sinai School of Medicine, New York 2Dana-Farber Cancer Institute, Boston, Massachusetts. Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA; Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne; University of Newcastle, Newcastle; Alan S. Coates, University of Sydney, Sydney, Australia; Olivia Pagani, Institute of Oncology of Southern... Department of Medicine, Harvard Medical School; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. [email protected] International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: [email protected]. From the Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA Karin Ribi, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Jürg Bernhard, International Breast Cancer Study Group Coordinating Center; and Bern University Hospital, Inselspital, Bern, Switzerland; Weixiu Luo, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, MA; Meredith M. Regan, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA; Gini F. Fleming,... From the European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute; Harvard School of Public Health; Frontier Science and Technology Research Foundation; Harvard Medical School, Boston, MA; Breast Center, Kantonsspital, St Gallen; International Breast Cancer Study Group, Swiss Group for Clinical Cancer Research, Bern; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Danish Breast Cancer Cooperative Group,... Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA Authors' Affiliations: 1Dana-Farber Cancer Institute; 2Harvard Medical School; 3Dana-Farber/Harvard Cancer Center; 4Beth Israel Deaconess Medical Center, Boston, Massachusetts; 5Department of Defense Prostate Cancer Clinical Trials Consortium, New York, NY; 6Sunnybrook Health Science Centre, Toronto, Ontario, Canada; 7Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon; 8M. D. Anderson Cancer Center, Houston, Texas; 9Johns Hopkins University School of Medicine, Baltimore, Maryland; 10Tulane Cancer Center, New Orleans, Louisiana; and 11GlaxoSmithKline, Research Triangle Park, North Carolina; Authors' Affiliations: 1Dana-Farber Cancer Institute; 2Harvard Medical School; 3Dana-Farber/Harvard Cancer Center; 4Beth Israel Deaconess Medical Center, Boston, Massachusetts; 5Department of Defense Prostate Cancer Clinical Trials Consortium, New York, NY; 6Sunnybrook Health Science Centre, Toronto, Ontario, Canada; 7Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon; 8M. D. Anderson Cancer Center, Houston, Texas; 9Johns Hopkins University School of Medicine, Baltimore, Maryland; 10Tulane Cancer Center, New Orleans, Louisiana; and 11GlaxoSmithKline, Research Triangle Park, North Carolina; Authors' Affiliations: 1Dana-Farber Cancer Institute; 2Harvard Medical School; 3Dana-Farber/Harvard Cancer Center; 4Beth Israel Deaconess Medical Center, Boston, Massachusetts; 5Department of Defense Prostate Cancer Clinical Trials Consortium, New York, NY; 6Sunnybrook Health Science Centre, Toronto, Ontario, Canada; 7Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon; 8M. D. Anderson Cancer Center, Houston, Texas; 9Johns Hopkins University School of Medicine, Baltimore, Maryland; 10Tulane Cancer Center, New Orleans, Louisiana; and 11GlaxoSmithKline, Research Triangle Park, North Carolina Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology,... Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School; Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation; Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation;... Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute & Harvard Medical School, 450 Brookline Avenue CLSB 11046, Boston, MA 02215, USA Instructor, Biometrics Center. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. [email protected] International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: [email protected]. 2Biostatistics, Dana-Farber Cancer Institute; From the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA. International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA. [email protected] International Breast Cancer Study Group Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. Electronic address: [email protected]. From the Tom Baker Cancer Center, Calgary; Cross Cancer Institute, Edmonton, Alberta; Princess Margaret Hospital, Toronto, Ontario; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Harvard School of Public Health; Dana-Farber/Harvard Cancer Center Renal Cancer Program, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Boston, MA; Medical University of South Carolina, Charleston, SC; and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH. Scooter Willis, Yuliang Sun, Mark Abramovitz, Brandon Young, Xiaoqian Lin, Justin Achua, Casey Williams, and Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Teng Fei, Meredith M. Regan, Kathryn P. Gray, Robert Gray, Victoria Wang, and Myles Brown, Dana-Farber Cancer Institute, Boston, MA; Min Ni, Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX; Bradley Long, Molecular Core, Scripps Florida, Jupiter, FL; Roswitha Kammler,... Irene L. Wapnir, Stanford University School of Medicine, Stanford, CA; Karen N. Price and Shari Gelber, Frontier Science and Technology Research Foundation, Richard D. Gelber, Frontier Science and Technology Research Foundation, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, Meredith M. Regan, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Stewart J. Anderson, University of Pittsburgh Graduate School of Public Health; Priya Rastogi,... Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston MA 02115; Karin Ribi, Aron Goldhirsch, and Jürg Bernhard, International Breast Cancer Study Group Coordinating Center; Jürg Bernhard, Bern University Hospital, Inselspital, Bern; Thomas Ruhstaller, Breast Center St Gallen, Swiss Group for Clinical Cancer Research, and International Breast Cancer Study Group, St Gallen, Switzerland; Weixiu Luo, Karen N. Price, Richard D. Gelber, and Meredith M. Regan, International Breast Cancer Study Group Statistical Center; Weixiu Luo, Harold J. Burstein, Richard D. Gelber, and... From the Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy; International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA; Department of Pathological Anatomy, University of Bari, Bari, Italy; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; Division of Pathology and Laboratory Medicine, European Institute of Oncology,... Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA Clinical Research Center and Laboratory of Human Nutrition, School of Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142; and IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA Laboratory of Human Nutrition, School of Science and Clinical Research Center, Massachusetts Institute of Technology, Cambridge 02139; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA From the Department of Medicine, Research Unit in Medical Senology, and Division of Pathology and Laboratory Medicine, European Institute of Oncology, Università degli Studi di Milano, Milan; Department of Pathological Anatomy, University of Bari, Bari; Centro di Riferimento Oncologico, Aviano, Italy; Department of Mathematics and Statistics, College of Engineering and Mathematical Sciences, University of Vermont, Burlington, VT; International Breast Cancer Study Group Statistical Center, Department of... Department of Biostatistics and Computational Biology Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts Dana Farber Cancer Institute, Boston, MA, USA Charles A. Dana Research Institute, Harvard-Thorndike General Clinical Research Centre, Beth Israel Deaconess Medical Centre and Harvard Medical School, Boston, Massachusetts, Biometrics Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts From the Departments of Epidemiology and Biostatistics and Urology, University of California, San Francisco, San Francisco, CA; Lank Center for Genitourinary Oncology, and Departments of Biostatistics and Computational Biology and Medical Oncology, Dana-Farber Cancer Institute; Harvard Medical School; Channing Laboratory, Brigham and Women's Hospital and Harvard School of Public Health, Boston, MA; and Fred Hutchinson Cancer Research Center, Seattle, WA. Marco Colleoni, International Breast Cancer Study Group, Bern, Switzerland; and European Institute of Oncology, Milan, Italy; Kathryn P. Gray, International Breast Cancer Study Group, Bern, Switzerland; and Dana-Farber Cancer Institute, Harvard T. H. Chen School of Public Health, Boston, MA; Richard D. Gelber, International Breast Cancer Study Group, Bern, Switzerland; Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School; and Frontier Science and Technology... From the Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan; Department of Pathological Anatomy, University of Bari, Bari; Division of Pathology, Centro di Riferimento Oncologico, Aviano; Anatomia Patologica, Spedali Civili di Brescia, Universita Degli Studi di Brescia, Brescia, Italy; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA; Institute of Oncology, Ljubljana... Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts International Breast Cancer Study Group Statistical Center Division of Biostatistics Dana‐Farber Cancer Institute, Harvard Medical School Boston Massachusetts Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA 02115; and Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology; Giuseppe Viale, University of Milan, Milan; Lorenzo Gianni, Ospedale degli Infermi, Rimini; Fabio Puglisi, University Hospital of Udine, University of Udine, Udine; Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo; Katia Cagossi, Ospedale di Carpi, Carpi, Italy; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center; Kathryn P.... |
Incoming Links
Showing number of triples: 1 to 314 of 314.